Merck & Co., US58933Y1055

Merck stock: Company schedules third-quarter 2026 earnings call for October 29

Published on 10/05/2026 at 07:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Merck & Co. will discuss its third-quarter 2026 performance on October 29. The company said a results release and supplemental materials will accompany the call replay.

Schwarzweiß-Dokumentarfoto einer pharmazeutischen Produktionslinie mit Arbeitern
Schwarzweiß-Reportage aus Produktionsanlage illustriert Pharmasektor von Merck & Co. Inc., ISIN US58933Y1055, dokumentarisch fotografiert, Illustration mit AI erstellt.

Merck & Co. has scheduled its third-quarter 2026 sales and earnings conference call for October 29, according to a company release dated October 1, 2026. Executives will provide an overview of the quarter’s performance during the call.

Merck sets October 29 call

The conference call is scheduled to begin at 9:00 a.m. ET. Investors, journalists and the public may access a live audio webcast, while the replay will be accompanied by the company’s sales and earnings release, supplemental financial disclosures and presentation slides. The announcement was issued by Merck & Co., Inc.

Before the Xetra open

The first price of the day is shown from the start of trading by the continuously updated real-time quote of Merck & Co. stock.

Disclaimer...

en | US58933Y1055 | MERCK & CO. | boerse | 70229688 | bgmi